4//SEC Filing
Ndu Adora 4
Accession 0001209191-23-052884
CIK 0001070494other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 5:30 PM ET
Size
7.1 KB
Accession
0001209191-23-052884
Insider Transaction Report
Form 4
Ndu Adora
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-10-12−4,381→ 4,381 total→ Common Stock (4,381 underlying) - Exercise/Conversion
Common Stock
2023-10-12+4,381→ 4,381 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F2]The restricted stock units shall vest in two equal annual installments commencing on the first anniversary of the grant date.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001865210
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 5:30 PM ET
- Size
- 7.1 KB